title: Activated extracellular signal-regulated kinases are necessary and sufficient to initiate tubulogenesis in renal tubular MDCK strain I cell cysts.
abstract: A classic in vitro model of renal cyst and tubule formation utilizes the Madin-Darby canine kidney (MDCK) cell line, of which two strains exist. Most cyst and tubule formation studies that utilized MDCK cells have been performed with MDCK strain II cells. MDCK strain II cells form hollow cysts in a three-dimensional collagen matrix over 10 days and tubulate in response to hepatocyte growth factor, which increases levels of active (phosphorylated) ERK1/2. In this study, we demonstrate that MDCK strain I cells also form cysts when grown in a collagen matrix; however, MDCK strain I cell cysts spontaneously initiate the primary steps in tubulogenesis. Analysis of time-lapse microscopy of both MDCK strain I and strain II cell cysts during the initial stages of tubulogenesis demonstrates a highly dynamic process with cellular extensions and retractions occurring rapidly and continuously. MDCK strain I cell cysts can spontaneously initiate tubulogenesis mainly because of relatively higher levels of active ERK in MDCK strain I, compared with strain II, cells. The presence of either of two distinct inhibitors of ERK activation (UO126 and PD09059) prevents tubulogenesis from occurring spontaneously in MDCK strain I cell cysts and, in response to hepatocyte growth factor, in strain II cell cysts. The difference between MDCK strain I and strain II cell lines is likely explained by differing embryological origins, with strain I cells being of collecting duct, and hence ureteric bud, origin. Ureteric bud cells also have high levels of active ERK and spontaneously tubulate in our in vitro collagen gel system, with tubulogenesis inhibited by UO126 and PD09059. These results suggest that a seminal event in kidney development may be the activation of ERK in the mesonephric duct/ureteric bud cells destined to form the collecting tubules.
authors.affiliation: Department of Medicine, University of Pennsylvania, Philadelphia 19104-6144, USA.
authors.forename: Nathan E
authors.initials: NE
authors.lastname: Hellman
authors.forename: Andres J
authors.initials: AJ
authors.lastname: Greco
authors.forename: Katherine K
authors.initials: KK
authors.lastname: Rogers
authors.forename: Chitra
authors.initials: C
authors.lastname: Kanchagar
authors.forename: Daniel F
authors.initials: DF
authors.lastname: Balkovetz
authors.forename: Joshua H
authors.initials: JH
authors.lastname: Lipschutz
mesh_terms: D000818:Animals; D002070:Butadienes / Q000494:pharmacology; D002460:Cell Line; D003560:Cysts / Q000473:pathology; D004285:Dogs; D048049:Extracellular Signal-Regulated MAP Kinases / Q000037:antagonists & inhibitors / Q000502:physiology*; D017228:Hepatocyte Growth Factor / Q000502:physiology; D007684:Kidney Tubules / Q000254:growth & development* / Q000502:physiology; D009570:Nitriles / Q000494:pharmacology; D016707:Tissue Fixation; D014513:Ureter / Q000166:cytology / Q000254:growth & development / Q000502:physiology
chemical_list: D002070:Butadienes; D009570:Nitriles; C113580:U 0126; D017228:Hepatocyte Growth Factor; D048049:Extracellular Signal-Regulated MAP Kinases